PubMed

Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertension.

Oudiz RJ, Galiè N, Olschewski H, Torres F, Frost A, Ghofrani HA, Badesch DB, McGoon MD, McLaughlin VV, Roecker EB, Harrison BC, Despain D, Dufton C, Rubin LJ; ARIES Study Group.

J Am Coll Cardiol. 2009 Nov 17;54(21):1971-81.PMID: 19909879 [PubMed - in process]Related articles

Pulmonary Arterial Hypertension: Baseline Characteristics From the REVEAL Registry.

Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, Barst RJ, Benza RL, Liou TG, Turner M, Giles S, Feldkircher K, Miller DP, McGoon M.

Chest. 2009 Oct 16. [Epub ahead of print]PMID: 19837821 [PubMed - as supplied by publisher]Related articles

Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol.

Badesch DB, McGoon MD, Barst RJ, Tapson VF, Rubin LJ, Wigley FM, Kral KM, Raphiou IH, Crater GD.

J Rheumatol. 2009 Oct;36(10):2244-9. Epub 2009 Sep 1.PMID: 19723905 [PubMed - in process]Related articles

End points and clinical trial design in pulmonary arterial hypertension.

McLaughlin VV, Badesch DB, Delcroix M, Fleming TR, Gaine SP, Galiè N, Gibbs JS, Kim NH, Oudiz RJ, Peacock A, Provencher S, Sitbon O, Tapson VF, Seeger W.

J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S97-107. Review.PMID: 19555863 [PubMed - indexed for MEDLINE]Related articles

Diagnosis and assessment of pulmonary arterial hypertension.

Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, Manes A, McGoon M, Naeije R, Olschewski H, Oudiz RJ, Torbicki A.

J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S55-66. Review.PMID: 19555859 [PubMed - indexed for MEDLINE]Related articles

Pulmonary function testing in patients with pulmonary arterial hypertension.

Jing ZC, Xu XQ, Badesch DB, Jiang X, Wu Y, Liu JM, Wang Y, Pan L, Li HP, Pu JL, Zhang ZL, Yang YJ.

Respir Med. 2009 Aug;103(8):1136-42. Epub 2009 Apr 28.PMID: 19403296 [PubMed - in process]Related articles

ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association.

McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J; American College of Cardiology Foundation Task Force on Expert Consensus Documents; American Heart Association; American College of Chest Physicians; American Thoracic Society, Inc; Pulmonary Hypertension Association.

J Am Coll Cardiol. 2009 Apr 28;53(17):1573-619. No abstract available. PMID: 19389575 [PubMed - indexed for MEDLINE]Related articles

ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association.

McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J, Harrington RA, Anderson JL, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Grines CL, Hlatky MA, Jacobs AK, Kaul S, Lichtenberg RC, Lindner JR, Moliterno DJ, Mukherjee D, Pohost GM, Rosenson RS, Schofield RS, Shubrooks SJ, Stein JH, Tracy CM, Weitz HH, Wesley DJ; ACCF/AHA.

Circulation. 2009 Apr 28;119(16):2250-94. Epub 2009 Mar 30. Review. No abstract available. Erratum in: Circulation. 2009 Jul 14;120(2):e13. PMID: 19332472 [PubMed - indexed for MEDLINE]Related articles

Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease.

Roberts KE, Fallon MB, Krowka MJ, Brown RS, Trotter JF, Peter I, Tighiouart H, Knowles JA, Rabinowitz D, Benza RL, Badesch DB, Taichman DB, Horn EM, Zacks S, Kaplowitz N, Kawut SM; Pulmonary Vascular Complications of Liver Disease Study Group.

Am J Respir Crit Care Med. 2009 May 1;179(9):835-42. Epub 2009 Feb 12.PMID: 19218192 [PubMed - indexed for MEDLINE]Related articles

Serotonin transporter polymorphisms in patients with portopulmonary hypertension.

Roberts KE, Fallon MB, Krowka MJ, Benza RL, Knowles JA, Badesch DB, Brown RS Jr, Taichman DB, Trotter J, Zacks S, Horn EM, Kawut SM; Pulmonary Vascular Complications of Liver Disease Study Group.

Chest. 2009 Jun;135(6):1470-5. Epub 2009 Jan 13.PMID: 19141529 [PubMed - indexed for MEDLINE]Related articles

Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.

Simonneau G, Rubin LJ, Galiè N, Barst RJ, Fleming TR, Frost AE, Engel PJ, Kramer MR, Burgess G, Collings L, Cossons N, Sitbon O, Badesch DB; PACES Study Group.

Ann Intern Med. 2008 Oct 21;149(8):521-30. Erratum in: Ann Intern Med. 2009 Jan 6;150(1):63. Ann Intern Med. 2009 Sep 15;151(6):435. PMID: 18936500 [PubMed - indexed for MEDLINE]Related articlesFree article

Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalities.

McGoon MD, Frost AE, Oudiz RJ, Badesch DB, Galie N, Olschewski H, McLaughlin VV, Gerber MJ, Dufton C, Despain DJ, Rubin LJ.

Chest. 2009 Jan;135(1):122-9. Epub 2008 Sep 23.PMID: 18812445 [PubMed - indexed for MEDLINE]Related articles

Surrogate and combined end points in pulmonary arterial hypertension.

Ventetuolo CE, Benza RL, Peacock AJ, Zamanian RT, Badesch DB, Kawut SM.

Proc Am Thorac Soc. 2008 Jul 15;5(5):617-22. Review.PMID: 18625754 [PubMed - indexed for MEDLINE]Related articlesFree article

Sitaxsentan for the treatment of pulmonary arterial hypertension: a 1-year, prospective, open-label observation of outcome and survival.

Benza RL, Barst RJ, Galie N, Frost A, Girgis RE, Highland KB, Strange C, Black CM, Badesch DB, Rubin L, Fleming TR, Naeije R.

Chest. 2008 Oct;134(4):775-82. Epub 2008 Jul 14. Erratum in: Chest. 2009 Apr;135(4):1114. PMID: 18625676 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical risk factors for portopulmonary hypertension.

Kawut SM, Krowka MJ, Trotter JF, Roberts KE, Benza RL, Badesch DB, Taichman DB, Horn EM, Zacks S, Kaplowitz N, Brown RS Jr, Fallon MB; Pulmonary Vascular Complications of Liver Disease Study Group.

Hepatology. 2008 Jul;48(1):196-203.PMID: 18537192 [PubMed - indexed for MEDLINE]Related articles

Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2.

Galiè N, Olschewski H, Oudiz RJ, Torres F, Frost A, Ghofrani HA, Badesch DB, McGoon MD, McLaughlin VV, Roecker EB, Gerber MJ, Dufton C, Wiens BL, Rubin LJ; Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy Studies (ARIES) Group.

Circulation. 2008 Jun 10;117(23):3010-9. Epub 2008 May 27.PMID: 18506008 [PubMed - indexed for MEDLINE]Related articlesFree article

Formulary management of recombinant factor VIIa at an academic medical center.

Owen PS, Golightly LK, MacLaren R, Ferretti KA, Badesch DB.

Ann Pharmacother. 2008 Jun;42(6):771-6. Epub 2008 May 13.PMID: 18477731 [PubMed - indexed for MEDLINE]Related articles

Sildenafil for pulmonary arterial hypertension associated with connective tissue disease.

Badesch DB, Hill NS, Burgess G, Rubin LJ, Barst RJ, Galiè N, Simonneau G; SUPER Study Group.

J Rheumatol. 2007 Dec;34(12):2417-22. Epub 2007 Nov 1.PMID: 17985403 [PubMed - indexed for MEDLINE]Related articles

Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines.

Badesch DB, Abman SH, Simonneau G, Rubin LJ, McLaughlin VV.

Chest. 2007 Jun;131(6):1917-28.PMID: 17565025 [PubMed - indexed for MEDLINE]Related articlesFree article

Potassium and phosphorus repletion in hospitalized patients: implications for clinical practice and the potential use of healthcare information technology to improve prescribing and patient safety.

Hemstreet BA, Stolpman N, Badesch DB, May SK, McCollum M.

Curr Med Res Opin. 2006 Dec;22(12):2449-55.PMID: 17257459 [PubMed - indexed for MEDLINE]Related articles

Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension.

McLaughlin VV, Oudiz RJ, Frost A, Tapson VF, Murali S, Channick RN, Badesch DB, Barst RJ, Hsu HH, Rubin LJ.

Am J Respir Crit Care Med. 2006 Dec 1;174(11):1257-63. Epub 2006 Aug 31.PMID: 16946127 [PubMed - indexed for MEDLINE]Related articlesFree article

Importance of right ventricular end-systolic regional wall stress in idiopathic pulmonary arterial hypertension: a new method for estimation of right ventricular wall stress.

Quaife RA, Chen MY, Lynch D, Badesch DB, Groves BM, Wolfel E, Robertson AD, Bristow MR, Voelkel NF.

Eur J Med Res. 2006 May 5;11(5):214-20.PMID: 16723296 [PubMed - indexed for MEDLINE]Related articles

Metastatic cancer while receiving continuous prostacyclin therapy.

Fagan KA, Bull TM, Badesch DB, Voelkel NF.

Chest. 2005 Dec;128(6 Suppl):619S-620S. No abstract available. PMID: 16373875 [PubMed - indexed for MEDLINE]Related articlesFree article

Autoimmunity and pulmonary hypertension: a perspective.

Nicolls MR, Taraseviciene-Stewart L, Rai PR, Badesch DB, Voelkel NF.

Eur Respir J. 2005 Dec;26(6):1110-8. Review.PMID: 16319344 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluation and management of the patient with pulmonary arterial hypertension.

Rubin LJ, Badesch DB.

Ann Intern Med. 2005 Aug 16;143(4):282-92. Review.PMID: 16103472 [PubMed - indexed for MEDLINE]Related articlesFree article

Pulmonary vascular manifestations of mixed connective tissue disease.

Bull TM, Fagan KA, Badesch DB.

Rheum Dis Clin North Am. 2005 Aug;31(3):451-64, vi. Review.PMID: 16084318 [PubMed - indexed for MEDLINE]Related articles

Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol.

Sitbon O, McLaughlin VV, Badesch DB, Barst RJ, Black C, Galiè N, Humbert M, Rainisio M, Rubin LJ, Simonneau G.

Thorax. 2005 Dec;60(12):1025-30. Epub 2005 Jul 29.PMID: 16055621 [PubMed - indexed for MEDLINE]Related articlesFree article

Survival with first-line bosentan in patients with primary pulmonary hypertension.

McLaughlin VV, Sitbon O, Badesch DB, Barst RJ, Black C, Galiè N, Rainisio M, Simonneau G, Rubin LJ.

Eur Respir J. 2005 Feb;25(2):244-9. Erratum in: Eur Respir J. 2005 May;25(5):942. PMID: 15684287 [PubMed - indexed for MEDLINE]Related articlesFree article

Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

Badesch DB, Abman SH, Ahearn GS, Barst RJ, McCrory DC, Simonneau G, McLaughlin VV; American College of Chest Physicians.

Chest. 2004 Jul;126(1 Suppl):35S-62S.PMID: 15249494 [PubMed - indexed for MEDLINE]Related articlesFree article

Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute/Office of Rare Diseases workshop.

Newman JH, Fanburg BL, Archer SL, Badesch DB, Barst RJ, Garcia JG, Kao PN, Knowles JA, Loyd JE, McGoon MD, Morse JH, Nichols WC, Rabinovitch M, Rodman DM, Stevens T, Tuder RM, Voelkel NF, Gail DB; National Heart, Lung and Blood Institute/Office of Rare Diseases.

Circulation. 2004 Jun 22;109(24):2947-52. No abstract available. PMID: 15210611 [PubMed - indexed for MEDLINE]Related articlesFree article

Prostanoid therapy for pulmonary arterial hypertension.

Badesch DB, McLaughlin VV, Delcroix M, Vizza CD, Olschewski H, Sitbon O, Barst RJ.

J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):56S-61S. Review.PMID: 15194179 [PubMed - indexed for MEDLINE]Related articles

Primary pulmonary hypertension, Castleman's disease and human herpesvirus-8.

Bull TM, Cool CD, Serls AE, Rai PR, Parr J, Neid JM, Geraci MW, Campbell TB, Voelkel NF, Badesch DB.

Eur Respir J. 2003 Sep;22(3):403-7.PMID: 14516126 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study.

Sitbon O, Badesch DB, Channick RN, Frost A, Robbins IM, Simonneau G, Tapson VF, Rubin LJ.

Chest. 2003 Jul;124(1):247-54.PMID: 12853530 [PubMed - indexed for MEDLINE]Related articlesFree article

Angiotensin-converting enzyme DD genotype in patients with primary pulmonary hypertension: increased frequency and association with preserved haemodynamics.

Abraham WT, Raynolds MV, Badesch DB, Wynne KM, Groves BM, Roden RL, Robertson AD, Lowes BD, Zisman LS, Voelkel NF, Bristow MR, Perryman MB.

J Renin Angiotensin Aldosterone Syst. 2003 Mar;4(1):27-30.PMID: 12692750 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension.

McLaughlin VV, Gaine SP, Barst RJ, Oudiz RJ, Bourge RC, Frost A, Robbins IM, Tapson VF, McGoon MD, Badesch DB, Sigman J, Roscigno R, Blackburn SD, Arneson C, Rubin LJ, Rich S; Treprostinil Study Group.

J Cardiovasc Pharmacol. 2003 Feb;41(2):293-9.PMID: 12548091 [PubMed - indexed for MEDLINE]Related articles

Pulmonary hypertension associated with connective tissue disease.

Fagan KA, Badesch DB.

Prog Cardiovasc Dis. 2002 Nov-Dec;45(3):225-34. Review.PMID: 12525998 [PubMed - indexed for MEDLINE]Related articles

Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension.

Langleben D, Christman BW, Barst RJ, Dias VC, Galiè N, Higenbottam TW, Kneussl M, Korducki L, Naeije R, Riedel A, Simonneau G, Hirsch AM, Rich S, Robbins IM, Oudiz R, McGoon MD, Badesch DB, Levy RD, Mehta S, Seeger W, Solèr M.

Am Heart J. 2002 May;143(5):E4.PMID: 12040360 [PubMed - indexed for MEDLINE]Related articles

Bosentan therapy for pulmonary arterial hypertension.

Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, Pulido T, Frost A, Roux S, Leconte I, Landzberg M, Simonneau G.

N Engl J Med. 2002 Mar 21;346(12):896-903. Erratum in: N Engl J Med 2002 Apr 18;346(16):1258. PMID: 11907289 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.

Channick RN, Simonneau G, Sitbon O, Robbins IM, Frost A, Tapson VF, Badesch DB, Roux S, Rainisio M, Bodin F, Rubin LJ.

Lancet. 2001 Oct 6;358(9288):1119-23.PMID: 11597664 [PubMed - indexed for MEDLINE]Related articles

Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension: a placebo-controlled study.

Channick R, Badesch DB, Tapson VF, Simonneau G, Robbins I, Frost A, Roux S, Rainisio M, Bodin F, Rubin LJ.

J Heart Lung Transplant. 2001 Feb;20(2):262-263. No abstract available. PMID: 11250530 [PubMed - as supplied by publisher]Related articles

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.

Badesch DB, Tapson VF, McGoon MD, Brundage BH, Rubin LJ, Wigley FM, Rich S, Barst RJ, Barrett PS, Kral KM, Jöbsis MM, Loyd JE, Murali S, Frost A, Girgis R, Bourge RC, Ralph DD, Elliott CG, Hill NS, Langleben D, Schilz RJ, McLaughlin VV, Robbins IM, Groves BM, Shapiro S, Medsger TA Jr.

Ann Intern Med. 2000 Mar 21;132(6):425-34.PMID: 10733441 [PubMed - indexed for MEDLINE]Related articlesFree article

Hyperuricemia in severe pulmonary hypertension.

Voelkel MA, Wynne KM, Badesch DB, Groves BM, Voelkel NF.

Chest. 2000 Jan;117(1):19-24.PMID: 10631193 [PubMed - indexed for MEDLINE]Related articlesFree article

Right ventricular phenotypic characteristics in subjects with primary pulmonary hypertension or idiopathic dilated cardiomyopathy.

Quaife RA, Lynch D, Badesch DB, Voelkel NF, Lowes BD, Robertson AD, Bristow MR.

J Card Fail. 1999 Mar;5(1):46-54.PMID: 10194660 [PubMed - indexed for MEDLINE]Related articles

The pressure-overloaded right ventricle in pulmonary hypertension.

Bristow MR, Zisman LS, Lowes BD, Abraham WT, Badesch DB, Groves BM, Voelkel NF, Lynch DM, Quaife RA.

Chest. 1998 Jul;114(1 Suppl):101S-106S. Review. No abstract available. PMID: 9676654 [PubMed - indexed for MEDLINE]Related articlesFree article

Pulmonary capillaritis: a possible histologic form of acute pulmonary allograft rejection.

Badesch DB, Zamora M, Fullerton D, Weill D, Tuder R, Grover F, Schwarz MI.

J Heart Lung Transplant. 1998 Apr;17(4):415-22.PMID: 9588587 [PubMed - indexed for MEDLINE]Related articles

Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium.

Lowes BD, Minobe W, Abraham WT, Rizeq MN, Bohlmeyer TJ, Quaife RA, Roden RL, Dutcher DL, Robertson AD, Voelkel NF, Badesch DB, Groves BM, Gilbert EM, Bristow MR.

J Clin Invest. 1997 Nov 1;100(9):2315-24.PMID: 9410910 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group.

Hinderliter AL, Willis PW 4th, Barst RJ, Rich S, Rubin LJ, Badesch DB, Groves BM, McGoon MD, Tapson VF, Bourge RC, Brundage BH, Koerner SK, Langleben D, Keller CA, Murali S, Uretsky BF, Koch G, Li S, Clayton LM, Jöbsis MM, Blackburn SD Jr, Crow JW, Long WA.

Circulation. 1997 Mar 18;95(6):1479-86.PMID: 9118516 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical trials in pulmonary hypertension.

Badesch DB.

Annu Rev Med. 1997;48:399-408. Review.PMID: 9046971 [PubMed - indexed for MEDLINE]Related articles

Coagulation and fibrinolytic profiles in patients with severe pulmonary hypertension.

Welsh CH, Hassell KL, Badesch DB, Kressin DC, Marlar RA.

Chest. 1996 Sep;110(3):710-7.PMID: 8797416 [PubMed - indexed for MEDLINE]Related articlesFree article

Colon perforation after lung transplantation.

Beaver TM, Fullerton DA, Zamora MR, Badesch DB, Weill D, Brown JM, Campbell DN, Grover FL.

Ann Thorac Surg. 1996 Sep;62(3):839-43.PMID: 8784016 [PubMed - indexed for MEDLINE]Related articles